prednimustine has been researched along with Hematologic Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M | 1 |
| Andersen, J; Christensen, L; Kongsholm, H | 1 |
| Christiansen, IE; Dombernowsky, P; Løber, J; Mattsson, W; Mouridsen, HT; Rørth, M | 1 |
| Arian-Schad, K; Hackl, A; Heydarfadai, M; Lahousen, M; Petru, E; Pickel, H; Stettner, H | 1 |
1 trial(s) available for prednimustine and Hematologic Diseases
| Article | Year |
|---|---|
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hallucinations; Hematologic Diseases; Humans; Middle Aged; Nausea; Prednimustine; Prednisolone; Random Allocation | 1983 |
3 other study(ies) available for prednimustine and Hematologic Diseases
| Article | Year |
|---|---|
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine | 2004 |
Phase II trial of prednimustine in glioblastoma multiforme.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Chlorambucil; Combined Modality Therapy; Drug Evaluation; Female; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Prednimustine; Time Factors | 1984 |
Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Epirubicin; Female; Hematologic Diseases; Humans; Neoplasm Staging; Ovarian Neoplasms; Pilot Projects; Prednimustine; Survival Rate | 1991 |